Anti-Cancer Effects of Green Tea by Either Anti- or Pro-Oxidative Mechanisms

  • Hayakawa, Sumio (Department of Cellular and Molecular Medicine, Medical Research Institute, Tokyo Medical and Dental University) ;
  • Saito, Kieko (Tea Science Center, University of Shizuoka) ;
  • Miyoshi, Noriyuki (Graduate School of Integrated Pharmaceutical and Nutritional Sciences, Graduate Program in Food and Nutritional Sciences, University of Shizuoka) ;
  • Ohishi, Tomokazu (Institute of Microbial Chemistry (BIKAKEN)) ;
  • Oishi, Yumiko (Department of Cellular and Molecular Medicine, Medical Research Institute, Tokyo Medical and Dental University) ;
  • Miyoshi, Mamoru (Tea Science Center, University of Shizuoka) ;
  • Nakamura, Yoriyuki (Tea Science Center, University of Shizuoka)
  • Published : 2016.06.01


Tea derived from the leaves and buds of Camellia sinensis (Theaceae) is consumed worldwide. Green tea contains various components with specific health-promoting effects, and is believed to exert protective effects against diseases including cancer, diabetes and hepatitis, as well as obesity. Of the various tea components, the polyphenol catechins have been the subject of extensive investigation and among the catechins, (-)-epigallocatechin gallate has the strongest bioactivity in most cases. Our research group has postulated that hepatocyte nuclear factor-$4{\alpha}$, sterol regulatory element-binding proteins, and tumor necrosis factor-${\alpha}$ are targets of green tea constituents including (-)-epigallocatechin gallate for their anti-diabetes, anti-obesity, and anti-hepatitis effects, respectively. Published papers were reviewed to determine whether the observed changes in these factors can be correlated with anti-cancer effects of green tea. Two major action mechanisms of (-)-epigallocatechin gallate have been proposed; one associated with its anti-oxidative properties and the other with its pro-oxidative activity. When reactive oxygen species are assumed to be involved, our findings that (-)-epigallocatechin gallate downregulated hepatocyte nuclear factor-$4{\alpha}$, sterol regulatory element-binding proteins, and tumor necrosis factor-${\alpha}$ may explain the anti-cancer effect of green tea as well. However, further studies are required to elucidate which determinant directs (-)-epigallocatechin gallate action as an anti-oxidant or a pro-oxidant for favorable activity.


  1. Abe K, Ijiri M, Suzuki T, et al (2005). Green tea with a high catechin content suppresses inflammatory cytokine expression in the galactosamine-injured rat liver. Biomed Res, 26, 187-92.
  2. Aw TY (1999). Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am J Clin Nutr, 70, 557-65.
  3. Babu PV, Liu D, Gilbert ER (2013). Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem, 24, 1777-89.
  4. Beltz LA, Bayer DK, Moss AL, et al (2006). Mechanisms of cancer prevention by green and black tea polyphenols. Anticancer Agents Med Chem, 6, 389-406.
  5. Bogdanski P, Suliburska J, Szulinska M, et al (2012). Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res, 32, 421-7.
  6. Chen KH, Li PC, Lin WH, et al (2011). Depression by a green tea extract of alcohol-induced oxidative stress and lipogenesis in rat liver. Biosci Biotechnol Biochem, 75, 1668-76.
  7. Choudhari SK, Chaudhary M, Bagde S, et al (2013). Nitric oxide and cancer: a review. World J Surg Oncol, 11, 118.
  8. Collins QF, Liu HY, Pi J, et al (2007). Epigallocatechin-3- gallate (EGCG), a green tea polyphenol, suppresses hepatic gluconeogenesis through 5'-AMP-activated protein kinase. J Biol Chem, 282, 30143-9.
  9. Gabitova L, Gorin A, Astsaturov I (2014). Molecular pathways: sterols and receptor signaling in cancer. Clin Cancer Res, 20, 28-34.
  10. Guo D, Bell EH, Mischel P, et al (2014). Targeting SREBP-1- driven lipid metabolism to treat cancer. Curr Pharm Des, 20, 2619-26.
  11. Huang WC, Li X, Liu J, et al (2012). Activation of androgen receptor, lipogenesis, and oxidative stress converged by SREBP-1 is responsible for regulating growth and progression of prostate cancer cells. Mol Cancer Res, 10, 133-42.
  12. Hwang JT, Ha J, Park IJ, et al (2007). Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett, 247, 115-21.
  13. Iso H, Date C, Wakai K, et al (2006). The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med, 144, 554-62.
  14. Jokinen E, Koivunen JP (2015). MEK and PI3K inhibition in solid tumors: rationale and evidence to date. Ther Adv Med Oncol, 7, 170-80.
  15. Kanadzu M, Lu Y, Morimoto K (2006). Dual function of (--)-epigallocatechin gallate (EGCG) in healthy human lymphocytes. Cancer Lett, 241, 250-5.
  16. Khan N, Mukhtar H (2010). Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev, 29, 435-45.
  17. Khan N, Mukhtar H (2013). Tea and health: studies in humans. Curr Pharm Des, 19, 6141-7.
  18. Koyama Y, Abe K, Sano Y, et al (2004). Effects of green tea on gene expression of hepatic gluconeogenic enzymes in vivo. Planta Med, 70, 1100-2.
  19. Lee IT, Yang CM (2013). Inflammatory signalings involved in airway and pulmonary diseases. Mediators Inflamm, 2013, 791231.
  20. Lee MH, Han DW, Hyon SH, et al (2011). Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-kappaB. Apoptosis, 16, 75-85.
  21. Lee MS, Kim CT, Kim Y (2009). Green tea (-)-epigallocatechin- 3-gallate reduces body weight with regulation of multiple genes expression in adipose tissue of diet-induced obese mice. Ann Nutr Metab, 54, 151-7.
  22. Li C, Yang W, Zhang J, et al (2014). SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma. Int J Mol Sci, 15, 7124-38.
  23. Li L, Steinauer KK, Dirks AJ, et al (2003). Radiation-induced cyclooxygenase 2 up-regulation is dependent on redox status in prostate cancer cells. Radiat Res, 160, 617-21.
  24. Li P, Wu M, Wang J, et al (2015). NAC selectively inhibit cancer telomerase activity: A higher redox homeostasis threshold exists in cancer cells. Redox Biol, 8, 91-7.
  25. Li X, Chen YT, Hu P, et al (2014b). Fatostatin displays high antitumor activity in prostate cancer by blocking SREBPregulated metabolic pathways and androgen receptor signaling. Mol Cancer Ther, 13, 855-66.
  26. Li X, Wu JB, Li Q, et al (2016). SREBP-2 promotes stem celllike properties and metastasis by transcriptional activation of c-Myc in prostate cancer. Oncotarget, 7, 12869-84.
  27. Lin KI, Lee SH, Narayanan R, et al (1995). Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol, 131, 1149-61.
  28. Liu HW, Chan YC, Wang MF, et al (2015). Dietary (-)-epigallocatechin-3-gallate supplementation counteracts aging-associated skeletal muscle insulin resistance and fatty liver in senescence-accelerated mouse. J Agric Food Chem, 63, 8407-17.
  29. Maeda-Yamamoto M, Suzuki N, Sawai Y, et al (2003). Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells. J Agric Food Chem, 51, 1858-63.
  30. Miyoshi N, Pervin M, Suzuki T, et al (2015). Green tea catechins for well-being and therapy: prospects and opportunities. Botanics: Targets Therapy, 5, 85-96.
  31. Motoshima H, Goldstein BJ, Igata M, et al (2006). AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol, 574, 63-71.
  32. Park IJ, Hwang JT, Kim YM, et al (2006). Differential modulation of AMPK signaling pathways by low or high levels of exogenous reactive oxygen species in colon cancer cells. Ann N Y Acad Sci, 1091, 102-9.
  33. Punathil T, Tollefsbol TO, Katiyar SK (2008). EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem Biophys Res Commun, 375, 162-7.
  34. Saeki K, Kobayashi N, Inazawa Y, et al (2002). Oxidationtriggered c-Jun N-terminal kinase (JNK) and p38 mitogenactivated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3- gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem J, 368, 705-20.
  35. Sakagami H, Satoh K (1997). Prooxidant action of two antioxidants: ascorbic acid and gallic acid. Anticancer Res, 17, 221-4.
  36. Santamarina AB, Oliveira JL, Silva FP, et al (2015). Green Tea Extract Rich in Epigallocatechin-3-Gallate Prevents Fatty Liver by AMPK Activation via LKB1 in Mice Fed a High- Fat Diet. PLoS One, 10, 141227.
  37. Sazuka M, Itoi T, Suzuki Y, et al (1996). Evidence for the interaction between (-)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Biosci Biotechnol Biochem, 60, 1317-9.
  38. Schwartz B, Algamas-Dimantov A, Hertz R, et al (2009). Inhibition of colorectal cancer by targeting hepatocyte nuclear factor-4alpha. Int J Cancer, 124, 1081-9.
  39. Sharma R, Tepas JJ, 3rd (2010). Microecology, intestinal epithelial barrier and necrotizing enterocolitis. Pediatr Surg Int, 26, 11-21.
  40. Shrestha S, Ehlers SJ, Lee JY, et al (2009). Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats. J Nutr, 139, 640-5.
  41. Singh BN, Shankar S, Srivastava RK (2011). Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol, 82, 1807-21.
  42. Steinberg GR, Kemp BE (2009). AMPK in Health and Disease. Physiol Rev, 89, 1025-78.
  43. Suganuma M, Sueoka E, Sueoka N, et al (2000). Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression. Biofactors, 13, 67-72.
  44. Suzuki Y, Miyoshi N, Miyoshi M (2012). Health-promoting effects of green tea. Proc Jpn Acad Ser B Phys Biol Sci, 88, 88-101.
  45. Tachibana H (2011). Green tea polyphenol sensing. Proc Jpn Acad Ser B Phys Biol Sci, 87, 66-80.
  46. Tsuneki H, Ishizuka M, Terasawa M, et al (2004). Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacol, 4, 18.
  47. Uchiyama Y, Suzuki T, Mochizuki K, et al (2013). Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats. J Agric Food Chem, 61, 11410-7.
  48. Waltner-Law ME, Wang XL, Law BK, et al (2002). Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem, 277, 34933-40.
  49. Wang S, Moustaid-Moussa N, Chen L, et al (2014). Novel insights of dietary polyphenols and obesity. J Nutr Biochem, 25, 1-18.
  50. Weber LW, Boll M, Stampfl A (2004). Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol, 10, 3081-7.
  51. Yang CS, Wang H (2011). Mechanistic issues concerning cancer prevention by tea catechins. Mol Nutr Food Res, 55, 819-31.
  52. Yang CS, Wang X, Lu G, et al (2009). Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer, 9, 429-39.
  53. Yang CS, Zhang J, Zhang L, et al (2016). Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res, 60, 160-74.
  54. Yasui K, Paeng N, Miyoshi N, et al (2012). Effects of a catechinfree fraction derived from green tea on gene expression of enzymes related to lipid metabolism in the mouse liver. Biomed Res, 33, 9-13.
  55. Yasui K, Tanabe H, Okada N, et al (2010). Effects of catechinrich green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells. Biomed Res, 31, 183-9.

Cited by

  1. Effects of Some Botanicals with Anti-Inflammatory and Antitoxic Activity vol.2016, pp.2314-7156, 2016,
  2. Green Tea Catechins for Prostate Cancer Prevention: Present Achievements and Future Challenges vol.6, pp.2, 2017,
  3. Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity vol.21, pp.10, 2016,
  4. Effect of the consumption of green tea extract during pregnancy and lactation on metabolism of mothers and 28d-old offspring vol.8, pp.1, 2018,
  5. Nontoxic Glucomoringin-Isothiocyanate (GMG-ITC) Rich Soluble Extract Induces Apoptosis and Inhibits Proliferation of Human Prostate Adenocarcinoma Cells (PC-3) vol.10, pp.9, 2018,
  6. In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-O-gallate (EGCG) with Proteins That Explain the Health Benefits of Green Tea vol.23, pp.6, 2018,